Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 8641-8650 of 13616

Page
per page
  1. Z-IETD-FMK
    B3232 Z-IETD-FMK
     37 Citation
    Target: Caspases
    Summary: Caspase-8 inhibitor
      ≥32.73 mg/mL
  2. Vinpocetine
    B2276 Vinpocetine
    Target: Phosphodiesterases (PDEs)
    Summary: PDE inhibitor
      ≥2.59 mg/mL
  3. Angiotensin 1/2 (5-7)
    A1049 Angiotensin 1/2 (5-7)
    Summary: Vasoconstrictor
      ≥36.5 mg/mL
  4. CC-223
    B6171 CC-223
    Summary: mTOR inhibitor, orally bioavailable
      insoluble in H2O; ≥108 mg/mL
  5. BI-9564
    B6184 BI-9564
    Summary: BRD9/7 specific inhibitor
      ≥8.82 mg/mL
      insoluble in H2O
  6. ML390
    B7824 ML390
    Summary: human DHODH inhibitor
      ≥40.6 mg/mL
  7. Cantharidic Acid (sodium salt)
    C3898 Cantharidic Acid (sodium salt)
    Summary: PP1 and PP2A inhibitor
  8. Halopemide
    C4385 Halopemide
    Summary: phospholipase D (PLD) inhibitor
      ≤10 mg/mL
  9. 2-hydroxy Flutamide
    C4721 2-hydroxy Flutamide
    Summary: androgen receptor inhibitor
      ≥27.4 mg/mL
  10. BMS-582949 hydrochloride
    B7850 BMS-582949 hydrochloride
    Summary: p38 MAPK inhibitor
      ≥44.3 mg/mL

Items 8641-8650 of 13616

Page
per page